Skip to main content
. 2021 Nov 18;148(1):70–79. doi: 10.1001/jamaoto.2021.3228

Figure 1. p16 As a Biomarker for Human Papillomavirus (HPV) Status in Patients With Oropharyngeal Squamous Cell Carcinoma (OPSCC) and Nonoropharyngeal Head and Neck Squamous Cell Carcinoma (Non-OP HNSCC).

Figure 1.

A, The effect size was 0.96 (95% CI, 0.90-0.98; P < .001) for differences between p16-negative and p16-positive values. B, The effect size was 0.32 (95% CI, –0.16 to 0.67; P = .09) for differences between p16-negative and p16-positive values. Boxes and whiskers indicate the HPV RNA load. ROC indicates receiver operating characteristic.